Pangenomic Health Inc. operates as a precision health company in Canada, offering the Nara App, a telehealth platform focused on mental health. The company faces significant concerns, including a current ratio of 0.02, indicating severe liquidity issues, and a troubling ROA of -1010.4%, reflecting poor asset efficiency. Additionally, the stock price has dropped 36% today, suggesting market volatility and investor uncertainty. While the telehealth sector is growing, these financial metrics raise red flags about the company's stability and operational effectiveness.
Loading financial metrics...
Company has $6K in cash but burned $54K last quarter. At this burn rate, only 0.1 quarters of runway remain without additional financing.
Company posted a loss of $-1.8M over the last year, representing Infinity% of revenue.
Debt of $125K is 19.7x the company's cash position of $6K.
Operating cash flow has been negative for 3 consecutive quarters, burning $217K over the last year.
No significant opportunities identified
Based on current financial metrics
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Health Information Services companies of a similar size
Based on 2025-Q2 (June 30, 2025)